Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2025

May 17, 2025

30561_dirs_2025-05-16_e525efab-ddc7-4a1f-88d9-50b8a4317382.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2025-05-14

Reporting Person: MORRISSEY MICHAEL (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-05-14 Common Stock M 308365 $18.80 Acquired 1931374 Direct
2025-05-14 Common Stock F 220494 $44.65 Disposed 1710880 Direct
2025-05-15 Common Stock F 104769 $44.65 Disposed 1606111 Direct
2025-05-16 Common Stock G 87871 Disposed 1518240 Direct
2025-05-16 Common Stock G 87871 Acquired 1852856 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-05-14 Option (right to buy) $18.80 M 308365 Disposed 2025-09-09 Common Stock (308365) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 17728 Indirect

Footnotes

F1: Includes 1,416,692 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and performance-based
restricted stock units ("PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each PSU represents a contingent right to receive one share of Common Stock.

F2: Represents a "net exercise" of an outstanding stock option to purchase 308,365 shares, and pursuant to which the Reporting Person received 87,871 shares, of Common Stock. The Issuer withheld 220,494 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using the closing stock price on May 14, 2025 of $44.65.

F3: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of RSUs awarded on March 4, 2022, April 3, 2023, and February 23, 2024.

F4: On May 16, 2025, the Reporting Person gifted 87,871 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended.

F5: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.

F6: Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 14, 2025.

F7: The option, representing the right to purchase a total of 308,365 shares of Common Stock, became fully exercisable on September 10, 2022.